In a predictable move, Bloomberg dropped another fear-laden headline on February 24, 2025: “Why a New Bat Coronavirus in China Is Raising Concern.” The piece, dripping with the outlet’s signature alarmism, spotlights a recently discovered bat-borne virus, HKU5-CoV-2, unearthed by scientists at China’s Wuhan Institute of Virology. CGN Network is here to cut through the noise and call it what it is: Bloomberg’s relentless pattern of fearmongering about coronaviruses, designed to keep readers hooked and markets jittery, while glossing over nuance for the sake of a good scare.
The Bloomberg Beat: Same Old Song
According to Bloomberg, this new virus uses the same human ACE2 receptor as SARS-CoV-2—the culprit behind COVID-19—prompting “global concerns” about another potential outbreak. The article breathlessly notes that the discovery “boosted shares of vaccine makers,” as if Wall Street’s knee-jerk reaction validates the threat. Sure, the Wuhan team found HKU5-CoV-2 in Pipistrellus bats across several Chinese provinces, and yes, it can theoretically latch onto human cells. But here’s what Bloomberg buries: there’s zero evidence of human infections, and experts, even in their own reporting, admit the risk is speculative at best.
This isn’t Bloomberg’s first rodeo. Remember 2020, when they amplified every whisper of COVID-19’s origins with ominous tones, from “China’s ‘Bat Woman’ Warns Coronavirus Is Just Tip of the Iceberg” to endless pieces tying bats to pandemics? Each time, the formula’s the same: spotlight a scientific finding, crank up the dread, and let the stock market do the rest. It’s less journalism, more theater—and CGN Network’s had enough of the act.
The Facts vs. The Fear
Let’s break it down. HKU5-CoV-2, identified in a study led by virologist Shi Zhengli, is a merbecovirus, related to MERS rather than COVID-19’s sarbecovirus family. Bloomberg leans hard on the ACE2 angle, but other outlets—like Reuters and The Economic Times—report what Bloomberg downplays: the virus binds to human receptors far less efficiently than SARS-CoV-2. Lab tests show it can infect human cells, sure, but its real-world ability to spark an epidemic? Slim to none, say scientists who aren’t chasing clicks. Dr. Michael Osterholm, cited elsewhere, called the reaction “overblown,” pointing to widespread immunity against similar viruses post-COVID.
Yet Bloomberg frames it as a ticking time bomb, tossing in buzzwords like “deforestation” and “climate change” to juice the narrative. They note the virus’s discovery lifted stocks for Moderna and Pfizer—up 6.6% and 2.6%, respectively—proving their fear sells. For a network like CGN, this smells less like public service and more like a playbook to manipulate markets and keep the panic cycle spinning.
Bloomberg’s Fearmongering Legacy
This fits Bloomberg’s pattern to a T. Back in 2020, they hyped Shi Zhengli’s warnings about bat coronaviruses as if Armageddon was imminent, only for years to pass without her “iceberg” sinking us. Their 2023 piece on COVID origins leaned heavily on unproven lab-leak theories, stirring the pot without evidence. Now, with HKU5-CoV-2, they’re at it again—taking a lab finding, skipping the “no human cases” context, and running straight to “global concern.” It’s not reporting; it’s fear porn, and it’s wearing thin.
Posts on X echo the skepticism CGN Network shares: “Bloomberg’s at it again with the bat virus scare—same old China panic playbook,” one user wrote. Another quipped, “Bloomberg sees a bat sneeze and calls it a pandemic. Yawn.” The sentiment’s clear: people are tired of being spoon-fed dread.
Why It Matters
For conservatives and patriots tuning into CGN, this isn’t just about Bloomberg’s bias—it’s about who benefits. Fear keeps the public docile, Big Pharma flush, and globalist agendas humming. Disney might bungle Snow White, but Bloomberg’s butchering the truth here is worse. HKU5-CoV-2 might warrant study, but it doesn’t deserve the hysteria Bloomberg’s peddling. The real concern? Not a bat in China, but a media giant that can’t stop crying wolf.
As Trump’s America First ethos takes root, CGN Network stands firm: we won’t let Bloomberg’s scare tactics dictate the narrative. HKU5-CoV-2’s a footnote, not a forecast—unless you’re buying stock in fear itself. Stay sharp, stay skeptical, and stick with CGN for the real story.